3,881
edits
Changes
Jump to navigation
Jump to search
Line 1,432:
Line 1,432: − + − + − + − + − + Line 1,460:
Line 1,460: − + − + Line 1,476:
Line 1,476: − + − + − + Line 1,492:
Line 1,492: − + − + − + − + + + Line 1,508:
Line 1,510: − + − + − + − + − + Line 1,524:
Line 1,526: − + − + − + Line 1,540:
Line 1,542: − + − + − + Line 1,622:
Line 1,624: − + − +
HAEM5:Volunteer Assignments and Opportunities (view source)
Revision as of 12:14, 22 December 2023
, 12:14, 22 December 2023no edit summary
|Hairy Cell Leukemia
|Hairy Cell Leukemia
|Snehal Patel, MD, PhD
|Snehal Patel, MD, PhD
|
|Complete
|
|
|
|
|-
|-
|[[HAEM5:Splenic marginal zone lymphoma|Splenic marginal zone lymphoma]]||Disease|| || || || || ||SG|| ||
|[[HAEM5:Splenic marginal zone lymphoma|Splenic marginal zone lymphoma]]||Disease|| || || || || ||SG|| ||
|
|Splenic Marginal Zone Lymphoma
|Snehal Patel, MD, PhD
|Snehal Patel, MD, PhD
|
|Complete
|
|
|
|
|-
|-
|[[HAEM5:Splenic diffuse red pulp small B-cell lymphoma|Splenic diffuse red pulp small B-cell lymphoma]]||Disease|| || || || || ||SG|| ||
|[[HAEM5:Splenic diffuse red pulp small B-cell lymphoma|Splenic diffuse red pulp small B-cell lymphoma]]||Disease|| || || || || ||SG|| ||
|
|Splenic Diffuse Red Pulp Small B-cell Lymphoma
|Snehal Patel, MD, PhD
|Snehal Patel, MD, PhD
|
|Complete
|
|
|
|
|
|
|
|
|
|Hairy Cell Leukemia Variant
|Snehal Patel, MD, PhD
|Snehal Patel, MD, PhD
|
|Complete
|
|
|
|
|
|
|
|
|
|Lymphoplasmacytic Lymphoma + Waldenstrom Macroglobulinemia
|Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and *Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI)
|Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and *Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI)
|
|Complete
|
|4/12/2023 by FQR
|
|
|-
|-
|
|
|
|
|
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)
|
|Whayoung Lee, MD (trainee), Fabiola Quintero-Rivera, MD, FACMG*
|
|
Department of Pathology and Laboratory Medicine and *Pediatrics, School of Medicine, University of California Irvine (UCI)
|Complete
|4/12/23 by FQR
|
|
|-
|-
|
|
|
|
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|[[HAEM5:Nodal marginal zone lymphoma|Nodal marginal zone lymphoma]]
|[[HAEM5:Nodal marginal zone lymphoma|Nodal marginal zone lymphoma]]
|
|
|
|
|
|Nodal Marginal Zone Lymphoma
|Andrew Ly, DO and Shivani Golem, PhD, FACMG
|Andrew Ly, DO and Shivani Golem, PhD, FACMG
|
|Complete
|
|5/28/2021
|
|
|-
|-
|
|
|
|
|
|Paediatric Nodal Marginal Zone Lymphoma
|* Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD
|* Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD
|
|Complete
|
|11/11/2020
|
|
|-
|-
|
|
|Linlin Gao, MD, PhD and Shivani Golem, PhD, FACMG
|Linlin Gao, MD, PhD and Shivani Golem, PhD, FACMG
|
|Complete
|
|09/10/2022
|
|
|-
|-